Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...

Your healthcare team can best advise you on treatment for COPD exacerbations ... Excess mucus raises your risk of bacterial infection, and a flare-up can indicate a bacterial infection.

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

In acute infective exacerbation of chronic bronchitis or chronic obstructive pulmonary disease (COPD), adding erdosteine to standard treatment significantly modified the outcome by improving the ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can ... system uses symptoms and exacerbations to grade the severity ...